five prime therapeutics inc
(FPRX:Consolidated Issue Listed on NASDAQ Global Select )
Peder K. Jensen M.D.
Advisor, Director, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee, Five Prime Therapeutics, Inc.
|Age||Total Calculated Compensation||This person is connected to 34 board members in 2 different organizations across 3 different industries.|
See Board Relationships
Dr. Peder K. Jensen, M.D., has been an Advisor of Five Prime Therapeutics, Inc. since 2011. Dr. Jensen serves as the President of BayWay Consultants, which he founded in 2010. He has more than 24 years of global drug development experience in both pharmaceutical and biotechnology companies, across many different therapeutic areas (neurology, cardiovascular, anti-infective, oncology and immunology). Over the course of his career, he was responsible for more than 40 new ...
Two Corporate DrivePhone: 415-365-5600
South San Francisco, California 94080
Board Members Memberships*
Director, Member of Compliance Committee and Member of Ad Hoc Business Development Committee
Former Director, Member of Compensation Committee, Member of Corporate Governance & Nominating Committee and Member of Audit Committee
Advisor, Director, Chairman of Nominating & Corporate Governance Committee and Member of Compensation Committee
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
|There is no Competitor Compensation data available.|